ArticleAnnals of translational medicine2019

Baseline serum lactate dehydrogenase level predicts survival benefit in patients with metastatic colorectal cancer receiving bevacizumab as first-line chemotherapy: a systematic review and meta-analysis of 7 studies and 1,219 patients.

Wanjing Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.